Aspergillus infections have grown in importance in the last years. However, most of the studies have focused on Aspergillus fumigatus, the most prevalent species in the genus. In certain locales and hospitals, Aspergillus flavus is more common in air than A. fumigatus, for unclear reasons. After A. fumigatus, A. flavus is the second leading cause of invasive aspergillosis and it is the most common cause of superficial infection. Experimental invasive infections in mice show A. flavus to be 100-fold more virulent than A. fumigatus in terms of inoculum required. Particularly common clinical syndromes associated with A. flavus include chronic granulomatous sinusitis, keratitis, cutaneous aspergillosis, wound infections and osteomyelitis following trauma and inoculation. Outbreaks associated with A. flavus appear to be associated with single or closely related strains, in contrast to those associated with A. fumigatus. In addition, A. flavus produces aflatoxins, the most toxic and potent hepatocarcinogenic natural compounds ever characterized. Accurate species identification within Aspergillus flavus complex remains difficult due to overlapping morphological and biochemical characteristics, and much taxonomic and population genetics work is necessary to better understand the species and related species. The flavus complex currently includes 23 species or varieties, including two sexual species, Petromyces alliaceus and P. albertensis. The genome of the highly related Aspergillus oryzae is completed and available; that of A. flavus in the final stages of annotation. Our understanding of A. flavus lags far behind that of A. fumigatus. Studies of the genomics, taxonomy, population genetics, pathogenicity, allergenicity and antifungal susceptibility of A. flavus are all required.
AbdallaM. H.1988; Prevalence of airborne Aspergillus flavus in Khartoum (Sudan) airspora with reference to dusty weather and inoculum survival in simulated summer conditions. Mycopathologia 104:137–141[CrossRef]
AcquatiF.,
SemeraroF.,
RespighiE.,
GallottiR.,
RepettoS.,
BinaghiG.1987; Aspergillus flavus -infection of a pacemaker wire: continuing evidence for active management of infected pacemakers. G Ital Cardiol 17:467–468
AdhikariA.,
SenM. M.,
Gupta-BhattacharyaS.,
ChandaS.2004; Airborne viable, non-viable, and allergenic fungi in a rural agricultural area of India: a 2-year study at five outdoor sampling stations. Sci Total Environ 326:123–141[CrossRef]
AlloM. D.,
MillerJ.,
TownsendT.,
TanC.1987; Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 317:1105–1108[CrossRef]
AlrajhiA. A.,
EnaniM.,
MahasinZ.,
Al-OmranK.2001; Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg 65:83–86
BaymanP.,
BakerJ. L.,
DosterM. A.,
MichailidesT. J.,
MahoneyN. E.2002; Ochratoxin production by the Aspergillus ochraceus group and Aspergillus alliaceus. Appl Environ Microbiol 68:2326–2329[CrossRef]
BowyerP.,
FraczekM.,
DenningD. W.2006; Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics 7:251[CrossRef]
BuffingtonJ.,
ReporterR.,
LaskerB. A.,
McNeilM. M.,
LansonJ. M.,
RossL. A.,
MascolaL.,
JarvisW. R.1994; Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 13:386–393[CrossRef]
CalvoA.,
GuarroJ.,
SuarezG.,
RamirezC.1980; Air-borne fungi in the air of Barcelona (Spain). III. The genus Aspergillus Link. Mycopathologia 71:41–43[CrossRef]
CameronJ. A.,
AntoniosS. R.,
CotterJ. B.,
HabashN. R.1991; Endophthalmitis from contaminated donor corneas following penetrating keratoplasty. Arch Ophthalmol 109:54–59[CrossRef]
CesaroS.,
ToffoluttiT.,
MessinaC.,
CaloreE.,
AlaggioR.,
CusinatoR.,
PillonM.,
ZanescoL.2004; Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Eur J Haematol 73:50–55[CrossRef]
ChakrabartiA.,
SethiS.,
RamanD. S.,
BeheraD.2002; Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 45:295–299[CrossRef]
Cheikh-RouhouF.,
MakniF.,
AyadiA.,
GhorbelR.,
Ben ZinaZ.2001; Ocular parasitoses and mycoses: cases diagnosed in the Central University Hospital of Sfax between 1996 and 1999. Bull Soc Pathol Exot 94:11–13
CooperJ. A.,
WeinbaumD. L.,
AldrichT. K.,
MandellG. L.1981; Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man. Am J Med 71:903–907[CrossRef]
CurrensJ.,
HutchesonP. S.,
SlavinR. G.,
CitardiM. J.2002; Primary paranasal Aspergillus granuloma: case report and review of the literature. Am J Rhinol 16:165–168
de ValkH. A.,
MeisJ. F.,
CurfsI. M.,
MuehlethalerK.,
MoutonJ. W.,
KlaassenC. H.2005; Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol 43:4112–4120[CrossRef]
DemiccoD. D.,
ReichmanR. C.,
VioletteE. J.,
WinnW. C.Jr1984; Disseminated aspergillosis presenting with endophthalmitis. A case report and a review of the literature. Cancer 53:1995–2001[CrossRef]
DenningD. W.,
RiniotisK.,
DobrashianR.,
SambatakouH.2003; Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature and review. Clin Infect Dis 37:S265–S280[CrossRef]
DenningD. W.,
MarrK. A.,
LauW. M.,
FacklamD. P.,
RatanatharathornV.,
BeckerC.,
UllmannA. J.,
SeibelN. L.,
FlynnP. M.other authors2006; Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect 53:337–349[CrossRef]
Diaz-GuerraT. M.,
MelladoE.,
Cuenca-EstrellaM.,
GaztelurrutiaL.,
NavarroJ. I. V.,
TudelaJ. L. R.2000; Genetic similarity among one Aspergillus flavus strain isolated from a patient who underwent heart surgery and two environmental strains obtained from the operating room. J Clin Microbiol 38:2419–2422
DoganM.,
PabuccuogluU.,
SariogluS.,
YucesoyM.2004; Isolated nasopharyngeal aspergillosis caused by A. flavus and associated with oxalosis. Ear Nose Throat J 83:331–333
EgelD. S.,
CottyP. J.,
EliasK. S.1994; Relationships among isolates of Aspergillus sect. Flavi that vary in aflatoxin production. Phytopathology 84:906–912[CrossRef]
Espinel-IngroffA.2003; Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991. J Clin Microbiol 41:403–409[CrossRef]
FrisvadJ. C.,
SkouboeP.,
SamsonR. A.2005; Taxonomic comparison of three different groups of aflatoxin producers and a new efficient producer of aflatoxin B1, sterigmatocystin and 3- O -methylsterigmatocystin, Aspergillus rambellii sp. nov. Syst Appl Microbiol 28:442–453[CrossRef]
GalaganJ. E.,
CalvoS. E.,
CuomoC.,
MaL. J.,
WortmanJ. R.,
BatzoglouS.,
LeeS. I.,
BasturkmenM.,
SpevakC. C.other authors2005; Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 438:1105–1115[CrossRef]
GeiserD. M.,
PittJ. I.,
TaylorJ. W.1998; Cryptic speciation and recombination in the aflatoxin-producing fungus Aspergillus flavus. Proc Natl Acad Sci U S A 95:388–393[CrossRef]
GeiserD. M.,
DornerJ. W.,
HornB. W.,
TaylorJ. W.2000; The phylogenetics of mycotoxin and sclerotium production in Aspergillus flavus and Aspergillus oryzae. Fungal Genet Biol 31:169–179[CrossRef]
GibsonA. M.,
BaranyiJ.,
PittM. J.,
EylesM. J.,
RobertsT. A.1994; Predicting fungal growth: the effect of water activity on Aspergillus flavus and related species. Int J Food Microbiol 23:419–431[CrossRef]
GottlichE.,
LangeB.,
FiedlerS.,
MelchertI.,
ReifenrathM.,
FlemmingH. C.,
Van der LubbeW.,
de HoogS.2002; Fungal flora in groundwater-derived public drinking water. Int J Hyg Environ Health 205:269–279[CrossRef]
GuarroJ.,
SoleM.,
CastanyR.,
CanoJ.,
TeixidoA.,
PujolI.,
GeneJ.,
CastroA.,
SardaP.2005; Use of random amplified microsatellites to type isolates from an outbreak of nosocomial aspergillosis in a general medical ward. Med Mycol 43:365–371[CrossRef]
GuineaJ.,
BouzaE.,
PeláezT.,
AlcaláL.2005; Evaluation of Czapeck agar and Sabouraud dextrose agar for the culture of airborne Aspergillus conidia. Diagn Microbiol Infect Dis 53:333–334[CrossRef]
GumaaS. A.,
MahgoubE. S.,
HayR. J.1992; Post-operative responses of paranasal Aspergillus granuloma to itraconazole. Trans R Soc Trop Med Hyg 86:93–94[CrossRef]
GuptaS. K.,
PereiraB. M.,
SinghA. B.1993; Survey of airborne culturable and non-culturable fungi at different sites in Delhi metropolis. Asian Pac J Allergy Immunol 11:19–28
HedayatiM. T.,
MayahiS.,
AghilR.,
GoharimoghadamK.2005; Airborne fungi in indoor and outdoor of asthmatic patients' home, living in the city of Sari. Iran J Allergy Asthma Immunol 4:189–191
HeinemannS.,
SymoensF.,
GordtsB.,
JannesH.,
NolardN.2004; Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. J Hosp Infect 57:149–155[CrossRef]
HsuehP. R.,
LauY. J.,
ChuangY. C.,
WanJ. H.,
HuangW. K.,
ShyrJ. M.,
YanJ. J.,
YuK. W.,
Jiunn-Jong WuJ. J.other authors2005; Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan Program Data from 2003. Antimicrob Agents Chemother 49:512–517[CrossRef]
ItoY.,
PetersonS. W.,
WicklowD. T.,
GotoT.2001; Aspergillus pseudotamarii , a new aflatoxin producing species in Aspergillus section Flavi. Mycol Res 105:233–239[CrossRef]
IwenP. C.,
RuppM. E.,
HinrichsS. H.1997; Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 24:1178–1184[CrossRef]
JamesM. J.,
LaskerB. A.,
McNeilM. M.,
SheltonM.,
WarnockD. W.,
ReissE.2000; Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol 38:3612–3618
KaliamurthyJ.,
GeraldineJ. P.,
ThomasP. A.2003; Disseminated aspergillosis due to Aspergillus flavus in an experimental model: efficacy of azole therapy. Mycoses 46:174–182[CrossRef]
KamaiY.,
HarasakiT.,
FukuokaT.,
OhyaS.,
UchidaK.,
YamaguchiH.,
KuwaharaS.2002; In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Antimicrob Agents Chemother 46:367–370[CrossRef]
KennedyC. A.,
AdamsG. L.,
NegliaJ. P.,
GiebinkG. S.1997; Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients. Otolaryngol Head Neck Surg 116:610–616[CrossRef]
KennedyH. F.,
SimpsonE. M.,
WilsonN.,
RichardsonM. D.,
MichieJ. R.1998; Aspergillus flavus endocarditis in a child with neuroblastoma. J Infect 36:126–127[CrossRef]
KhanZ. U.,
SandhuR. S.,
RandhawaH. S.,
MenonM. P.,
DusajI. S.1976; Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects. Scand J Respir Dis 57:73–87
KhanZ. U.,
GopalakrishnanG.,
Al-AwadiK.,
GuptaR. K.,
MoussaS. A.,
ChughT. D.,
KrajciD.1995; Renal aspergilloma due to Aspergillus flavus. Clin Infect Dis 21:210–212[CrossRef]
KlichM. A.,
MullaneyE. J.1987; DNA restriction enzyme fragment length polymorphism as a tool for differentiation of Aspergillus flavus and Aspergillus oryzae. Exp Mycol 11:170–175[CrossRef]
KlichM. A.,
PittJ. L.1988; Differentiation of Aspergillus flavus from A. parasiticus and other closely related species. Trans Br Mycol Soc 91:99–108[CrossRef]
KumedaY.,
AsaoT.1996; Single-strand conformation polymorphism analysis of PCR-amplified ribosomal DNA internal transcribed spacers to differentiate species of Aspergillus section Flavi. Appl Environ Microbiol 62:2947–2952
KurosawaM.,
KobayashiS.,
YanagiharaY.,
ShidaT.1990; A case of occupational allergic bronchopulmonary aspergillosis unique to Japan. Br J Clin Pract 44:482–489
KurtzmanC. P.,
SmileyM. J.,
RobnettC. J.,
WicklowD. T.1986; DNA relatedness among wild and domesticated species in the Aspergillus flavus group. Mycologia 78:955–959[CrossRef]
KurtzmanC. P.,
HornB. W.,
HesseltineC. W.1987; Aspergillus nomius , a new aflatoxin-producing species related to Aspergillus flavus and Aspergillus tamarii. Antonie van Leeuwenhoek 53:147–158[CrossRef]
LanceS. E.,
FribergT. R.,
KowalskiR. P.1988; Aspergillus flavus endophthalmitis and retinitis in an intravenous drug abuser. A therapeutic success. Ophthalmology 95:947–949[CrossRef]
Lass-FlorlC.,
KoflerG.,
KropshoferG.,
HermansJ.,
KreczyA.,
DierichM. P.,
NiederwieserD.1998; In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42:497–502[CrossRef]
Lass-FlorlC.,
NaglM.,
SpethC.,
UlmerH.,
DierichM. P.,
WürznerR.2001; Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother 45:124–128[CrossRef]
LiD. M.,
HorieY.,
WangY.,
LiR.1998; Three new Aspergillus species isolated from clinical sources as a causal agent of human aspergillosis. Mycoscience 39:299–305[CrossRef]
LinkH.F.1809; Observationes in Ordines plantarum naturales. Dissertatio prima, complectens Anandrarum ordines Epiphytas, Mucedines Gastomycos et Fungos Der Gesellschaft Naturforschender Freunde zu Berlin. Magazin für die neuesten Entdeckungen in der gesamten Naturkunde 3:1–42
LionakisM. S.,
LewisaR. L.,
TorresaH. A.,
AlbertaN. D.,
RaadaI. I.,
KontoyiannisaD. P.2005; Increased frequency of non- fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52:15–20[CrossRef]
MaertensJ.,
RaadI.,
PetrikkosG.,
BoogaertsM.,
SelleslagD.,
PetersenF. B.,
SableC. A.,
KartsonisN. A.,
NgaiA.other authors2004; Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563–1571[CrossRef]
MalleaM.,
MurrayI. G.,
SegretainG.,
PhilpotC. M.,
CharpinH.,
GuehoE.,
CharpinJ.1972; Census of Aspergillus colonies in the air comparison between. London, Paris, Lyon, Marseilles: Acta Allergol 27:273–278[CrossRef]
MariA.,
RiccioliD.2004; The Allergome Web Site – a database of allergenic molecules. Aim, structure, and data of a web-based resource. 60th Annual Meeting American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 113:S301
MarrK. A.,
CarterR. A.,
CrippaF.,
WaldA.,
CoreyL.2002; Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34:909–917[CrossRef]
MilosevB.,
el-MahgoubS.,
AalO. A.,
el-HassanA. M.1969; Primary aspergilloma of paranasal sinuses in the Sudan. A review of seventeen cases. Br J Surg 56:132–137[CrossRef]
MoodyS. F.,
TylerB. M.1990; Restriction enzyme analysis of mitochondrial DNA of the Aspergillus flavus group: A. flavus, A. parasiticus , and A. nomius. Appl Environ Microbiol 56:2441–2452
MorganJ.,
WannemuehlerK. A.,
MarrK. A.,
HadleyS.,
KontoyiannisD. P.,
WalshT. J.,
FridkinS. K.,
PappasP. G.,
WarnockD. W.2005; Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 43:Suppl. 1S49–S58[CrossRef]
MosqueraJ.,
WarnP. A.,
MorrisseyJ.,
MooreC. B.,
Gil-LamaignereC.,
DenningD. W.2001; Susceptibility testing of Aspergillus flavus : inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo. Antimicrob Agents Chemother 45:1456–1462[CrossRef]
MoubasherA. H.,
Abdel-FattahH. M.,
SwelimM. A.1981; Studies on air-borne fungi at Qena. I. Seasonal fluctuations. Z Allg Mikrobiol 21:247–253[CrossRef]
MyokenY.,
SugataT.,
FujitaY.,
KyoT.,
FujiharaM.,
KoharaT.,
KatsuM.,
MikamiY.2003; Molecular epidemiology of invasive stomatitis due to Aspergillus flavus in patients with acute leukemia. J Oral Pathol Med 32:215–218[CrossRef]
NozawaK.,
SekitaS.,
HaradaM.,
UdagawaS.,
KawaiK.1989; Isolation and structures of two new indoloterpenes related to aflavine from a microsclerotium-producing strain of Aspergillus flavus. Chem Pharm Bull (Tokyo) 37:626–630[CrossRef]
OakleyK. L.,
MooreC. B.,
DenningD. W.1998; In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrob Agents Chemother 42:2726–2730
OddsF. C.,
GervenF. V.,
Espinel-IngroffA.,
BartlettM. S.,
GhannoumM. A.,
LancasterM. V.,
PfallerM. A.,
RexJ. H.,
RinaldiM. G.,
WalshT. J.1998; Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 42:282–288
PandaN. K.,
BalajiP.,
ChakrabartiA.,
SharmaS. C.,
ReddyC. E.2004; Paranasal sinus aspergillosis: its categorization to develop a treatment protocol. Mycoses 47:277–283[CrossRef]
PatersonR. R.,
KelleyJ.,
GallagherM.1997; Natural occurrence of aflatoxins and Aspergillus flavus (Link) in water. Lett Appl Microbiol 25:435–436[CrossRef]
PatersonP. J.,
SeatonS.,
PrenticeH. G.,
KibblerC. C.2003; Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J Antimicrob Chemother 52:873–876[CrossRef]
Perez-ArellanoJ. L.,
Angel-MorenoA.,
BelonE.,
FrancesA.,
SantanaO. E.,
Martin-SanchezA. M.2001; Isolated renoureteric aspergilloma due to Aspergillus flavus : case report and review of the literature. J Infect 42:163–165[CrossRef]
PetersonS. W.2000; Phylogenetic relationships in Aspergillus based on rDNA sequence analysis. In Integration of Modern Taxonomic Methods for Penicillium and Aspergillus Classification pp 323–355 edited by
SamsonR. A.,
PittJ. I.
Amsterdam: Harwood Academic Publishers;
PetersonS. W.,
ItoY.,
HornB. W.,
GotoT.2001; Aspergillus bombycis , a new aflatoxigenic species and genetic variation in its sibling species, A. nomius. Mycologia 93:689–703[CrossRef]
PfallerM. A.,
MesserS. A.,
HollisR. J.,
JonesR. N. Sentry Participants Group (2002). Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000. Antimicrob Agents Chemother 46:1032–1037[CrossRef]
RamaniR.,
HazarikaP.,
KapadiaR. D.,
ShivanandaP. G.1994; Invasive maxillary aspergillosis in an otherwise healthy individual. Ear Nose Throat J 73:420–422
RathP. M.,
AnsorgR.1997; Value of environmental sampling and molecular typing of aspergilli to assess nosocomial sources of aspergillosis. J Hosp Infect 37:47–53[CrossRef]
RigoK.,
VargaJ.,
TothB.,
TerenJ.,
MesterhazyA.,
KozakiewiczZ.2002; Evolutionary relationships within Aspergillus section Flavi based on sequences of the intergenic transcribed spacer regions and the 5.8S rRNA gene. J Gen Appl Microbiol 48:9–16[CrossRef]
SaitoM.,
TsurataO.1993; A new variety of Aspergillus flavus from tropical soil in Thailand and its aflatoxin productivity. Proc Jpn Assoc Mycotoxicol 37:31–36
SamsonR. A.,
HoekstraE. S.,
FrisvadJ. C.,
FiltenborgO.2000; Identification of the common food and airborne fungi, Aspergillus
. In Introduction to Food and Airborne Fungi pp 64–97 Utrecht: Centraalbureau voor Schimmekultures;
SaravananK.,
PandaN. K.,
ChakrabartiA.,
DasA.,
BapurajR. J.2006; Allergic fungal rhinosinusitis: an attempt to resolve the diagnostic dilemma. Arch Otolaryngol Head Neck Surg 132:173–178[CrossRef]
ScheideggerK. A.,
PayneG. A.2003; Unlocking the secrets behind secondary metabolism: a review of Aspergillus flavus from pathogenicity to functional genomics. J Toxicol 22:423–459
SeoK.,
AkiyoshiH.,
OhnishiY.1999; Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus. Microbiol Immunol 43:1017–1025[CrossRef]
SingerS.,
SingerD.,
RuchelR.,
MergeryanH.,
SchmidtU.,
HarmsK.1998; Outbreak of systemic aspergillosis in a neonatal intensive care unit. Mycoses 41:223–227[CrossRef]
SridharM. S.,
GargP.,
BansalA. K.,
GopinathanU.2000; Aspergillus flavus keratitis after laser in situ keratomileusis. Am J Ophthalmol 129:802–804[CrossRef]
StaibF.,
RajendranC.,
MishraS. K.,
VoigtR.,
LindlarF.,
HartmannC.,
WeberR.,
NowotnyP.1983; An atypical Aspergillus flavus from a case of bronchopulmonary aspergilloma. A contribution to the cultural and serological diagnosis of A. flavus infections. Zentralbl Bakteriol Mikrobiol Hyg [A] 255:361–367
StammbergerH.,
JakseR.,
BeaufortF.1984; Aspergillosis of the paranasal sinuses: x-ray diagnosis, histopathology, and clinical aspects. Ann Otol Rhinol Laryngol 93:251–256[CrossRef]
SuttonD. A.,
SothergillQ. A.,
RinaldiM. F.2004; Aspergillus in vitro antifungal susceptibility data: new millennium trends. In Advances Against Aspergillosis , Medical Mycological Society of America, San Francisco, California, Sept 9–11, abstract no. 16. Med Mycol 43:Suppl. 1S1–S319
Taj-AldeenS. J.,
HilalA. A.,
Chong-LopezA.2003; Allergic Aspergillus flavus rhinosinusitis: a case report from Qatar. Eur Arch Otorhinolaryngol 260:331–335[CrossRef]
Tran-DihnN.,
PittJ. I.,
CarterD. A.1999; Molecular genotype analysis of natural toxigenic and nontoxigenic isolates of Aspergillus flavus and A. parasiticus. Mycol Res 103:1485–1490[CrossRef]
VandenBerghM. F.,
VerweijP. E.,
VossA.1999; Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn Microbiol Infect Dis 34:221–227[CrossRef]
VujanovicV.,
SmoragiewiczW.,
KrzysztyniakK.2001; Airborne fungal ecological niche determination as one of the possibilities for indirect mycotoxin risk assessment in indoor air. Environ Toxicol 16:1–8[CrossRef]
WangL.,
YokoyamaK.,
TakahasiH.,
KaseN.,
HanyaY.,
YashiroK.,
MiyajiM.,
NishimuraK.2001; Identification of species in Aspergillus section Flavi based on sequencing of the mitochondrial cytochrome b gene. Int J Food Microbiol 71:75–86[CrossRef]
WarrisA.,
GaustadP.,
MeisJ. F.,
VossA.,
VerweijP. E.,
AbrahamsenT. G.2001; Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect 47:143–148[CrossRef]
WongT. Y.,
FongK. S.,
TanD. T.1997; Clinical and microbial spectrum of fungal keratitis in Singapore: a 5-year retrospective study. Int Ophthalmol 21:127–130[CrossRef]
YagiH. I.,
GumaaS. A.,
ShumoA. I.,
AbdallaN.,
GadirA. A.1999; Nasosinus aspergillosis in Sudanese patients: clinical features, pathology, diagnosis, and treatment. J Otolaryngol 28:90–94
YuJ.2004; Genetics and biochemistry of mycotoxin synthesis. In Fungal Biotechnology in Agricultural, Food, and Environmental Applications vol. 21 pp 343–361 edited by
AroraD. K.
New York: Marcel Dekker;
YuJ.,
WhitelawC. A.,
NiermanW. C.,
BhatnagarD.,
ClevelandT. E.2004; Aspergillus flavus expressed sequence tags for identification of genes with putative roles in aflatoxin contamination of crops. FEMS Microbiol Lett 237:333–340
YuJ.,
ClevelandT. E.,
NiermanW. C.,
BennettJ. W.2005; Aspergillus flavus genomics: gateway to human and animal health, food safety, and crop resistance to diseases. Rev Iberoam Micol 22:194–202[CrossRef]